Equity Analysis /
United States of America

US : Amneal Pharmaceuticals Inc. - AMRX | 1Q22 Financials: While Generics Market Withers, AMRX Continues to Progress Key Growth Drivers

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    5 May 2022
    Published by